Sander A. Flaum, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 4,680 shares at $53.94 ($252K) on 2018-03-06, disclosed to the SEC on 2018-03-07.
Open-market sale of $252k EGRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.94 | 2,340 | $126K | 50.0% |
| 2 | $53.94 | 2,340 | $126K | 50.0% |
| Total | $53.94 avg | 4,680 | $252K | 100% |
| Filing → |